Julie Gannon | Investor Relations Officer |
Kirk Huntsman | Chairman and Chief Executive Officer |
Brad Amman | Chief Financial Officer |
Scott Henry | ROTH Capital Partners |
Lucas Ward | Ascendiant Capital Markets |
Good day, everyone, and welcome to the Vivos Therapeutics Fourth Quarter and Full Year 2022 Earnings Conference Call. At this time participants are in a listen-only mode. A question-and-answer session will follow management’s remarks. This conference call is being recorded, and a replay of today's call will be available on the Investor Relations section of Vivos' website and will remain posted for the next 30 days.
I will now hand the call over to Julie Gannon, Vivos' Investor Relations Officer for introductions and the reading of the Safe harbor.